MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

Use of Steroids to Treat Spasticity in MS

MStranslate
September 29, 2014
Research, Treatments
By Brett Drummond Spasticity is a common symptom in people with multiple sclerosis, having a major impact on quality of life and imposing a financial burden. There are a number of current treatments for...

Anxiety and Depression in People with MS

MStranslate
September 9, 2014
Research
By Brett Drummond While there have been some reports suggesting higher rates of anxiety and depression in people with multiple sclerosis, the results have been conflicting. Last week, results were published...

Changes in Blood Proteins Before Onset of MS Symptoms

MStranslate
August 22, 2014
Research
By Brett Drummond Whilst it is understood that multiple sclerosis is caused by a combination of both genetic and environmental factors, the exact cause(s) remains unknown. One of the biggest difficulties...

Movement Disorders in Multiple Sclerosis

MStranslate
July 28, 2014
Movement Disorders, Research
Neurologist Dr Andrew Evans provides an introduction to the Melbourne Brain Centre's Movement Disorders team, and discusses their work on using Botox to help treat symptoms, such as tremors, in people living...
exercise

Using Exercise to Minimise Fatigue in MS

MStranslate
July 21, 2014
Lifestyle, Research
By Brett Drummond Fatigue is a common symptom of multiple sclerosis (MS), that can range from creating minor difficulties to having a severe impact on quality of life. The causes of fatigue in people with...

Eye Movement Research in Multiple Sclerosis

MStranslate
June 30, 2014
Ocular Motor
Associate Professor and Neuro-ophthalmologist, Owen White MD, introduces the Melbourne Brain Centre's Ocular Motor research team and talks about eye movement research in relation to multiple...

MERTK – A Susceptibility Gene in Multiple Sclerosis

MStranslate
May 28, 2014
Basic Sciences, Research
Professor Trevor Kilpatrick, Director of the Melbourne Neuroscience Institute, discusses the discovery of a new susceptibility gene for multiple sclerosis, MERTK.  The video highlights how this gene was...

Genetics & Multiple Sclerosis – A/Prof Helmut Butzkueven

MStranslate
May 28, 2014
Basic Sciences, Research
Associate Professor Helmut Butzkueven discusses the importance of understanding the genetic markers of multiple sclerosis and explains the research currently being undertaken by the Basic Sciences team in...

A New Marker to Predict MS Progression

MStranslate
May 27, 2014
Basic Sciences
When people are diagnosed with MS, it is very difficult to predict how their condition will progress as each individual will often have different outcomes. This leads to a large level of uncertainty for the...

The PET/CT Scanner & Its Uses for Multiple Sclerosis

MStranslate
May 2, 2014
Neuroimaging
Professor Roger Ordidge, Chair of Imaging Science at the University of Melbourne, provides an insight into the new PET/CT scanner located at the Melbourne Brain Centre and explains how it might help people...
  1. 27
  2. 28
  3. 29
  4. 30
  5. 31
  6. 32
  7. 33

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.